Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US69329Y1047
Ticker PDLI
Company PDL BIOPHARMA
Currency $
Price
Aware Investor Index (AII) 98.5965
Recommendation STRONG BUY
P/E 2.32
ROE 21.98 %
Capitalization 354,912,180 $
Dividend Yield 27.65 %
P/S 0.60
AII Position 40
P/E Position 2
ROE Position 141
Capitalization Position 777
Dividend Yield Position 2
Sales 590,448,000 $
10-Year Average Earnings 152,946,700 $
Shares Outstanding 163,554,000
Equity 695,952,000 $
Dividend per Share 0.6 $
Industry Biotechnology
Country United States
PDL BIOPHARMA Investor Relations Web Site http://investor.pdl.com







Sales:

YEAR MONTH AMOUNT
2015 12 590,448,000.00 $
2014 12 581,225,000.00 $
2013 12 442,921,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 332,795,000.00 $
2014 12 322,244,000.00 $
2013 12 264,530,000.00 $
2012 12 211,669,000.00 $
2011 12 199,389,000.00 $
2010 12 91,874,000.00 $
2009 12 189,660,000.00 $
2008 12 68,387,000.00 $
2007 12 -21,061,000.00 $
2006 12 -130,020,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 695,952,000.00 $
2014 12 460,437,000.00 $
2013 12 113,489,000.00 $
2012 12 -68,122,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 163,554,000
2014 12 173,110,000
2013 12 159,343,000
2012 12 146,403,000

 












Bloomberg News for PDL BIOPHARMA:

Feb 10, 2012
Nasdaq Short Interest as of Jan. 31
283 64,685 PDII PDI INC 37,088 35,330 10,856 PDLI PDL BIOPHARMA IN 15,552,112 15,369,417 2,425,494 PGC PEAPACK GLADSTON...
Nov 2, 2001
Computer Sciences Posts Lower Earnings
include charges of $0.17 per share after-tax related to September 11. Protein Design (PDLI ) posted $0.02 3Q loss vs. $0.06 loss on 74% revenue rise. The company expects breakeven...
Jul 5, 2005
PowerPicks Heat Up in June
4,339 NR None 5 - Health Care Equipment PDLI Protein Design Labs 1,731 C 400 5 - Biotechnology...
May 20, 2002
MIM Raises EPS Outlook
therapy for treatment of metastatic breast cancer and other solid tumors. Protein Design (PDLI ) says Phase III results of its Zamyl in patients with relapsed or refractory acute myeloid...
May 10, 2002
US Airways Mulls Bankruptcy
revenue rise, and sees 8%-11% higher Q2 EBITDA on a 7%-10% revenue rise. Protein Design (PDLI ) posted $0.02 vs. $0.07 Q1 EPS on 18% lower revenue. The drug maker sees a $0.17-$0...
May 7, 2002
S&P Downgrades Broadcom on Loss of Motorola Contract
times the enterprise value-to-EBITDA multiple -- 20% below peers. Protein Design Labs (PDLI ): Upgrades to 3 STARS (hold) from 1 STAR (sell) Analyst: Frank DiLorenzo S&P...
Mar 21, 2002
Morgan Stanley Upgrades Protein Design to 'Overweight'
Morgan Stanley upgraded Protein Design (PDLI ) to overweight from underweight. The biotech company doesn't plan additonal development of Zenapax as a therapy for psoriasis, as the...
Dec 1, 2003
Pacific Growth Ups Protein Design to 'Overweight'
Pacific Growth upgraded Protein Design Labs (PDLI ) to overweight. Protein Design and Genentech agreed in principle...
Feb 1, 2002
Waste Management Shares Take a Spill
II suppliers. JP Morgan upgraded. CIBC World reiterates strong buy on Protein Design (PDLI ), citing the time line for the release of efficacy data for two key pipeline compounds...
Nov 9, 2011
U.S. Companies Reporting Positive EPS Surprises, Nov. 9
-1.82 -4.31 ASH# ASHLAND INC 1.01 1.05 -3.8 0.93 8.6 -5.16 -9.35 PDLI# PDL BIOPHARMA IN 0.28 0.24 16.7 0.26 7.7 -0.19 -3.10 ENS# ENERSYS ...


Google News for PDL BIOPHARMA:

Post Registrar - 12 hours ago
Analysts Speculate on Pdl Biopharma Inc (PDLI) and Seaspan Corp ...
Pdl Biopharma Inc (NASDAQ:PDLI)'s share price soared 0.58% or 0.02 to reach at $3.47 during previous trading session. A total of 942405 ...
USA Commerce Daily
Drilling Down Into PDL BioPharma, Inc. (PDLI)
PDL BioPharma, Inc. (PDLI) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the ...
Herald KS
Should Value Investors Consider PDL BioPharma, Inc. (PDLI) Stock?
Let's put PDL BioPharma, Inc. PDLI stock into this equation and find out if it is a good choice for value-oriented investors right now, or if ...
AllStockNews
Pdl Biopharma Inc (PDLI) Showing Signs of Potential Bullish ...
Pdl Biopharma Inc (PDLI) shares are on close watch heading into the week as the price has moved above the Balance Step indicator, revealing ...
StockNewsJournal - 3 days ago
Technicals in Review for Pdl Biopharma Inc (PDLI)
Investors may be studying recent technical signals on shares of Pdl Biopharma Inc (PDLI). Watching the longer-term MACD oscillator indicator, ...
FactsReporter
PDL BioPharma (PDLI) Reports $25M Share Buyback Program
PDL BioPharma, Inc. (NASDAQ: PDLI) announced today that PDL's board of directors has authorized a new stock repurchase program to ...
Economic News
Pdl Biopharma Inc (PDLI) Share Performance Recap
Pdl Biopharma Inc (PDLI) shares are showing positive signals short-term as the stock has finished higher by 1.46% for the week. In taking a ...
Post Analyst
Buy or Sell? Average Brokerage Ratings on PDL BioPharma, Inc ...
PDL BioPharma, Inc. (NASDAQ:PDLI) plunged -0.86% with the closing price of $3.46. The overall volume in the last trading session was 3.39 ...
Nasdaq - 20 Sep 2017
PDL BioPharma, Inc. (PDLI) stock surged 41.39% during past quarter
PDL BioPharma, Inc. (PDLI) recently closed with rise of 2.72% to its 20-Day Simple Moving Average. This short time frame picture represents ...
Stock Talker - 17 hours ago
Analysts' Review under Consideration: Pdl Biopharma Inc (PDLI ...
Pdl Biopharma Inc (NASDAQ:PDLI)'s share price plunged -0.29% or -0.01 to reach at $3.45 during previous trading session. A total of 1.73 ...


Back